164 related articles for article (PubMed ID: 27391789)
1. Hypoxia Responsive, Tumor Penetrating Lipid Nanoparticles for Delivery of Chemotherapeutics to Pancreatic Cancer Cell Spheroids.
Kulkarni P; Haldar MK; Katti P; Dawes C; You S; Choi Y; Mallik S
Bioconjug Chem; 2016 Aug; 27(8):1830-8. PubMed ID: 27391789
[TBL] [Abstract][Full Text] [Related]
2. Tissue-Penetrating, Hypoxia-Responsive Echogenic Polymersomes For Drug Delivery To Solid Tumors.
Kulkarni P; Haldar MK; Karandish F; Confeld M; Hossain R; Borowicz P; Gange K; Xia L; Sarkar K; Mallik S
Chemistry; 2018 Aug; 24(48):12490-12494. PubMed ID: 29968262
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-Responsive, Polymeric Nanocarriers for Targeted Drug Delivery to Estrogen Receptor-Positive Breast Cancer Cell Spheroids.
Mamnoon B; Feng L; Froberg J; Choi Y; Sathish V; Mallik S
Mol Pharm; 2020 Nov; 17(11):4312-4322. PubMed ID: 32926627
[TBL] [Abstract][Full Text] [Related]
4. Nanocarriers responsive to a hypoxia gradient facilitate enhanced tumor penetration and improved anti-tumor efficacy.
Zhen J; Tian S; Liu Q; Zheng C; Zhang Z; Ding Y; An Y; Liu Y; Shi L
Biomater Sci; 2019 Jul; 7(7):2986-2995. PubMed ID: 31106796
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-responsive folic acid conjugated glycol chitosan nanoparticle for enhanced tumor targeting treatment.
Jang EH; Shim MK; Kim GL; Kim S; Kang H; Kim JH
Int J Pharm; 2020 Apr; 580():119237. PubMed ID: 32201251
[TBL] [Abstract][Full Text] [Related]
6. Mmp-9 responsive PEG cleavable nanovesicles for efficient delivery of chemotherapeutics to pancreatic cancer.
Kulkarni PS; Haldar MK; Nahire RR; Katti P; Ambre AH; Muhonen WW; Shabb JB; Padi SK; Singh RK; Borowicz PP; Shrivastava DK; Katti KS; Reindl K; Guo B; Mallik S
Mol Pharm; 2014 Jul; 11(7):2390-9. PubMed ID: 24827725
[TBL] [Abstract][Full Text] [Related]
7. Targeting the Tumor Core: Hypoxia-Responsive Nanoparticles for the Delivery of Chemotherapy to Pancreatic Tumors.
Confeld MI; Mamnoon B; Feng L; Jensen-Smith H; Ray P; Froberg J; Kim J; Hollingsworth MA; Quadir M; Choi Y; Mallik S
Mol Pharm; 2020 Aug; 17(8):2849-2863. PubMed ID: 32521162
[TBL] [Abstract][Full Text] [Related]
8. Fucoidan-Manganese Dioxide Nanoparticles Potentiate Radiation Therapy by Co-Targeting Tumor Hypoxia and Angiogenesis.
Shin SW; Jung W; Choi C; Kim SY; Son A; Kim H; Lee N; Park HC
Mar Drugs; 2018 Dec; 16(12):. PubMed ID: 30558324
[TBL] [Abstract][Full Text] [Related]
9. Growth of Metastatic Triple-Negative Breast Cancer Is Inhibited by Deep Tumor-Penetrating and Slow Tumor-Clearing Chemotherapy: The Case of Tumor-Adhering Liposomes with Interstitial Drug Release.
Stras S; Howe A; Prasad A; Salerno D; Bhatavdekar O; Sofou S
Mol Pharm; 2020 Jan; 17(1):118-131. PubMed ID: 31825626
[TBL] [Abstract][Full Text] [Related]
10. MgO nanoparticles coated with polyethylene glycol as carrier for 2-Methoxyestradiol anticancer drug.
Alfaro A; León A; Guajardo-Correa E; Reúquen P; Torres F; Mery M; Segura R; Zapata PA; Orihuela PA
PLoS One; 2019; 14(8):e0214900. PubMed ID: 31415561
[TBL] [Abstract][Full Text] [Related]
11. An Oxygen Self-sufficient Fluorinated Nanoplatform for Relieved Tumor Hypoxia and Enhanced Photodynamic Therapy of Cancers.
Ma S; Zhou J; Zhang Y; Yang B; He Y; Tian C; Xu X; Gu Z
ACS Appl Mater Interfaces; 2019 Feb; 11(8):7731-7742. PubMed ID: 30694643
[TBL] [Abstract][Full Text] [Related]
12. Enhanced targeting of 3D pancreatic cancer spheroids by aptamer-conjugated polymeric micelles with deep tumor penetration.
Tian L; Pei R; Zhong L; Ji Y; Zhou D; Zhou S
Eur J Pharmacol; 2021 Mar; 894():173814. PubMed ID: 33352182
[TBL] [Abstract][Full Text] [Related]
13. Targeted polymeric nanoparticles for drug delivery to hypoxic, triple-negative breast tumors.
Mamnoon B; Loganathan J; Confeld MI; De Fonseka N; Feng L; Froberg J; Choi Y; Tuvin DM; Sathish V; Mallik S
ACS Appl Bio Mater; 2021 Feb; 4(2):1450-1460. PubMed ID: 33954285
[TBL] [Abstract][Full Text] [Related]
14. Targeting Tumor Hypoxia Using Nanoparticle-engineered CXCR4-overexpressing Adipose-derived Stem Cells.
Jiang X; Wang C; Fitch S; Yang F
Theranostics; 2018; 8(5):1350-1360. PubMed ID: 29507625
[TBL] [Abstract][Full Text] [Related]
15. Enhancing the chemotherapy effect of Apatinib on gastric cancer by co-treating with salidroside to reprogram the tumor hypoxia micro-environment and induce cell apoptosis.
Zhang Z; Yang W; Ma F; Ma Q; Zhang B; Zhang Y; Liu Y; Liu H; Hua Y
Drug Deliv; 2020 Dec; 27(1):691-702. PubMed ID: 32397840
[TBL] [Abstract][Full Text] [Related]
16. Nano-sensitizer with self-amplified drug release and hypoxia normalization properties potentiates efficient chemoradiotherapy of pancreatic cancer.
Yu S; Jiang Y; Li Q; Li M; Su J; Lai S; Gan Z; Ding Z; Yu Q
Biomaterials; 2024 Oct; 310():122634. PubMed ID: 38823195
[TBL] [Abstract][Full Text] [Related]
17. Large-Pore Functionalized Mesoporous Silica Nanoparticles as Drug Delivery Vector for a Highly Cytotoxic Hybrid Platinum-Acridine Anticancer Agent.
Zheng Y; Fahrenholtz CD; Hackett CL; Ding S; Day CS; Dhall R; Marrs GS; Gross MD; Singh R; Bierbach U
Chemistry; 2017 Mar; 23(14):3386-3397. PubMed ID: 28122141
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-Responsive Polymersomes for Drug Delivery to Hypoxic Pancreatic Cancer Cells.
Kulkarni P; Haldar MK; You S; Choi Y; Mallik S
Biomacromolecules; 2016 Aug; 17(8):2507-13. PubMed ID: 27303825
[TBL] [Abstract][Full Text] [Related]
19. Integration of cascade delivery and tumor hypoxia modulating capacities in core-releasable satellite nanovehicles to enhance tumor chemotherapy.
Wang J; Wang X; Lu SY; Hu J; Zhang W; Xu L; Gu D; Yang W; Tang W; Liu F; Cao Y; Liu H
Biomaterials; 2019 Dec; 223():119465. PubMed ID: 31518842
[TBL] [Abstract][Full Text] [Related]
20. PEGylated self-assembled enzyme-responsive nanoparticles for effective targeted therapy against lung tumors.
Guo F; Wu J; Wu W; Huang D; Yan Q; Yang Q; Gao Y; Yang G
J Nanobiotechnology; 2018 Jul; 16(1):57. PubMed ID: 30012166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
